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Improved immunogenicity of Newcastle disease virus inactivated vaccine following 
DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and 
fusion protein genes 
ABSTRACT 
The present study describes the development of DNA vaccines using the hemagglutinin-
neuraminidase (HN) and fusion (F) genes from AF2240 Newcastle disease virus strain, 
namely pIRES/HN, pIRES/F and pIRES-F/HN. Transient expression analysis of the 
constructs in Vero cells revealed the successful expression of gene inserts in vitro. Moreover, 
in vivo experiments showed that single vaccination with the constructed plasmid DNA 
(pDNA) followed by a boost with inactivated vaccine induced a significant difference in 
enzyme-linked immunosorbent assay antibody levels (p < 0.05) elicited by either pIRES/F, 
pIRES/F+  pIRES/HN or pIRES-F/HN at one week after the booster in specific pathogen free 
chickens when compared with the inactivated vaccine alone. Taken together, these results 
indicated that recombinant pDNA could be used to increase the efficacy of the inactivated 
vaccine immunization procedure. 
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